AstraZeneca PLC
(XTER:ZEG)
€
147.7
0.8 (0.54%)
Market Cap: 228.63 Bil
Enterprise Value: 253.41 Bil
PE Ratio: 38.61
PB Ratio: 6.56
GF Score: 88/100 - Q1 2024 AstraZeneca PLC Earnings Call TranscriptApr 25, 2024€141.15 (+6.45%)Earnings
- AstraZeneca PLC Sustainability 2023 Highlights Summary Call TranscriptMar 22, 2024
- Q4 2023 AstraZeneca PLC Earnings Call TranscriptFeb 08, 2024€115.95 (-6.04%)Earnings
- AstraZeneca PLC at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 AstraZeneca PLC Earnings Call TranscriptNov 09, 2023€120.95 (+2.41%)Earnings
- Q2 2023 AstraZeneca PLC Earnings Call TranscriptJul 28, 2023€130 (+3.88%)Earnings
- AstraZeneca PLC at ASCO Investor Meeting (Virtual) TranscriptJun 05, 2023
- Q1 2023 AstraZeneca PLC Earnings Call TranscriptApr 27, 2023€133.4 (-0.30%)Earnings
- Q4 2022 AstraZeneca PLC Earnings Call TranscriptFeb 09, 2023€126.55 (+4.59%)Earnings
- Q4 2022 AstraZeneca PLC Earnings Presentation (Pre-Recorded) TranscriptFeb 09, 2023
- Q3 2022 AstraZeneca PLC Earnings Presentation TranscriptNov 10, 2022
- Q2 2022 AstraZeneca PLC Earnings Call TranscriptJul 29, 2022€130.5 (-0.34%)Earnings
- AstraZeneca PLC Meet AZN management: American Society of Clinical Oncology 2022 Annual Meeting TranscriptJun 06, 2022
- Q1 2022 AstraZeneca PLC Earnings Call TranscriptApr 29, 2022€127.9 (+2.20%)Earnings
- AstraZeneca PLC Investor Science Conference Call: ASCO GU 2022 TranscriptFeb 23, 2022
- Full Year 2021 AstraZeneca PLC Earnings Call TranscriptFeb 10, 2022€103.34 (+3.73%)Earnings
- AstraZeneca PLC Investor science conference call: ASCO GI 2022 TranscriptJan 24, 2022
- AstraZeneca PLC at OTC Markets and Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptNov 17, 2021
- Q3 2021 AstraZeneca PLC Earnings Call TranscriptNov 12, 2021€103.02 (-6.58%)Earnings
- AstraZeneca PLC ESMO Investor Science Conference Call TranscriptSep 20, 2021
- Q2 2021 AstraZeneca PLC Earnings Call TranscriptJul 29, 2021€97.18 (+0.05%)Earnings
- AstraZeneca PLC Meet AZN Management: Oncology - 2021 ASCO Annual Meeting TranscriptJun 07, 2021
- Q1 2021 AstraZeneca PLC Earnings Call TranscriptApr 30, 2021Earnings
- AstraZeneca PLC BioPharmaceuticals Virtual Event - New CVRM: Emerging Pipeline TranscriptMar 25, 2021
- AstraZeneca PLC BioPharmaceuticals Virtual Event - Opening and Q&A Session TranscriptMar 25, 2021
- Full Year 2020 AstraZeneca PLC Earnings Call TranscriptFeb 11, 2021€82.6 (-0.18%)Earnings
- AstraZeneca PLC to Acquire Alexion Pharmaceuticals Inc Call TranscriptDec 12, 2020
- Q3 2020 AstraZeneca PLC Earnings Call TranscriptNov 05, 2020€94.55 (-0.10%)Earnings
- AstraZeneca PLC Investor Conference Call: Farxiga's DAPA-CKD Trial at ESC 2020 TranscriptAug 30, 2020
- Q2 2020 AstraZeneca PLC Earnings Call TranscriptJul 30, 2020€98.46 (+2.55%)Earnings
- AstraZeneca PLC at ASCO Virtual Scientific Program TranscriptJun 01, 2020
- Q1 2020 AstraZeneca PLC Earnings Call TranscriptApr 29, 2020€94.15 (-0.33%)Earnings
- Silence Therapeutics PLC Collaboration With AstraZeneca and R&D Update Call TranscriptMar 25, 2020
- Full Year 2019 AstraZeneca PLC Earnings Call TranscriptFeb 14, 2020€87.79 (-3.51%)Earnings
- AstraZeneca PLC Investor Science Conference Call - ASH 2019 TranscriptDec 10, 2019
- AstraZeneca PLC Investor Science Conference Call - ACR 2019 TranscriptNov 13, 2019
- AstraZeneca PLC Investor Science Conference Call - ASN 2019 TranscriptNov 10, 2019
- Q3 2019 AstraZeneca PLC Earnings Call TranscriptOct 24, 2019€84.82 (+5.50%)Earnings
- AstraZeneca PLC Investor Science Conference Call: ESMO 2019 TranscriptSep 30, 2019
- AstraZeneca PLC Investor Science Conference Call: Farxiga's DAPA-HF trial at ESC TranscriptSep 01, 2019
- Q2 2019 AstraZeneca PLC Earnings Call TranscriptJul 25, 2019€77.49 (+7.48%)Earnings
- AstraZeneca PLC at ASCO Annual Meeting TranscriptJun 03, 2019
- AstraZeneca PLC Annual Shareholders Meeting TranscriptApr 26, 2019
- Q1 2019 AstraZeneca PLC Earnings Call TranscriptApr 26, 2019€67.84 (-1.82%)Earnings
- AstraZeneca PLC to Discuss Strategic Collaboration in Oncology of Trastuzumab Deruxtecan (DS-8201) with Daiichi Sankyo Co Ltd Call TranscriptMar 29, 2019
- Daiichi Sankyo Co Ltd and AstraZeneca PLC DS-8201 Strategic Collaboration Presentation TranscriptMar 29, 2019
- Full Year 2018 AstraZeneca PLC Earnings Call TranscriptFeb 14, 2019€70.32 (+7.06%)Earnings
AstraZeneca PLC Investor Science Conference Call: Farxiga's DAPA-HF trial at ESC Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)